Utilizing a Protocol Cost Savings Analysis to Reduce Drug Development Costs

By PharmaSeek
Published: August 2018

By Jill K. Shilbauer, Director of Strategic Initiatives, With Contributions by Amanda Miller, Training Manager, PFS Clinical, and Nicolas Cindric, CEO, PharmaSeek Companies

Protocol Cost Savings Analysis (PCSA) is a promising tool that will directly impact pharmaceutical manufacturers’ R & D expenses. This white paper discusses how using a PCSA to align protocol procedures with routine care allows for significant cost savings.

To learn more, register to download this free white paper.

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

PharmaSeek is an industry leader in administrative services for clinical research.